Adjustment for the baseline reported consumption of any alcohol did not materially affect the relative risk for the primary outcome (relative risk with treatment, 0.88; 97% CI, 0.72 to 1.07; P = 0.16). The frequency of intravenous glucose administration in the newborn did not differ significantly between groups.